SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-038538
Filing Date
2023-02-14
Accepted
2023-02-14 13:38:55
Documents
2
Group Members
MSD CREDIT OPPORTUNITY MASTER FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d406333dsc13ga.htm SC 13G/A 70269
2 EX-99.1 d406333dex991.htm EX-99.1 6584
  Complete submission text file 0001193125-23-038538.txt   78694
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Subject) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88072 | Film No.: 23626572
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017
Business Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017 (212) 303-1650
MSD Partners, L.P. (Filed by) CIK: 0001514334 (see all company filings)

IRS No.: 271522220 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A